Sandoz to acquire Oriel Therapeutics, gaining rights to portfolio of respiratory products targeting asthma and COPD
April 19, 2010

PrimeraDx Announces the Expansion of its Senior Management Team
March 22, 2010

Dr. Thomas Hofstaetter Named President and CEO of VaxInnate
March 18, 2010

Valeritas Announces Appointment of New CFO
March 17, 2010

Medicus Insurance Company Offers New Policy Endorsement
March 16, 2010

Resolvyx and Collaborators Publish Study Showing Potential of Neuroprotectin D1 (NPD1) To Treat Neovascular Eye Disease
March 12, 2010

Vertos Medical's Prospective Outcomes Study Demonstrates Efficacy, Validates Safety Profile of mild®
March 12, 2010

Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
March 2, 2010

Acute Study Demonstrates Safety of Vertos Medical's mild® Procedure; Findings Appear in Pain Physician Journal
February 24, 2010

Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal™ for Fabry Disease
February 11, 2010

CMT and Ameritox Announce Partnership to Combat Opioid Overuse
February 1, 2010

Vertos Medical Completes Enrollment in U.S. IRB I Study of mild®
January 21, 2010

CMT and Gateway Health Plan to Present Medical Management Strategies for Behavioral Healthcare Patients in Special Needs Plans
January 20, 2010

VaxInnate licenses recombinant H1N1 Pandemic Swine Flu vaccine to Biological E.
January 12, 2010